InMode (InMode) Current Deferred Revenue : $10.9 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InMode Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

InMode's current deferred revenue for the quarter that ended in Dec. 2023 was $10.9 Mil.

InMode Current Deferred Revenue Historical Data

The historical data trend for InMode's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Current Deferred Revenue Chart

InMode Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

15.59

11.90

13.81

13.80

10.92

InMode Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Deferred Revenue	Get a 7-Day Free Trial															13.80	17.29	11.10	10.63	10.92

InMode Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of InMode's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

InMode (InMode) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

154:Germany 154:Germany

Address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206

Website

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.